Sweden· SE-19910524000012
Eldepryl 10 mg Tablett
A medicinal product containing selegiline hydrochloride, registered in Sweden by Orion Corporation.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Selegiline Hydrochloride
- Manufacturer
- Orion Corporation
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19910524000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Selegiline hydrochloride in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEldepryl 10mg tabletsOrion Pharma (UK) Ltd
- FinlandEldeprylOrion Corporation
- NorwayEldeprylOrion Corporation
- United StatesEMSAMViatris Specialty LLC
- GermanySelegilin Al 10Aliud Pharma Gmbh
- ItalyJUMEXCHIESI ITALIA S.P.A.
- PolandSeganZakłady Farmaceutyczne POLPHARMA S.A.
- BelgiumEldepryl 10 mgOrion
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Eldepryl
- Bulgaria · Jamax, Селегос
- Cyprus · Selegos, Selex
- Germany · Selegilin Neuraxpharm
- Denmark · Eldepryl
- Spain · Plurimen
- Finland · Eldepryl
- France · Deprenyl
- United Kingdom (Northern Ireland) · Eldepryl, Selegiline Hydrochloride Activase Pharmaceuticals
- Greece · Feliselin
- Ireland · Eldepryl
- Italy · Jumex, Selecom
- Luxembourg · Eldepryl
- Latvia · Eldepryl
- Norway · Eldepryl
- Poland · Selgres
- Portugal · Selegilina Generis
- Romania · Selegos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0a913e8c-c8f2-4aa6-a7d3-39e16f223e30 GET /v1/drugs/0a913e8c-c8f2-4aa6-a7d3-39e16f223e30?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19910524000012",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19910524000012",
"product_doc_link": "https://docetp.mpa.se/LMF/Eldepryl%20tablet%20SmPC_09001bee807a0e07.pdf"
}See everything about selegiline hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.